1. |
MARON B J, TOWBIN J A, THIENE G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention[J]. Circulation,2006,113:1807-16..
|
2. |
FU M. Autoimmunity in idiopathic dilated cardiomyopathy: from patients to molecules and back to patients[J]. Int J Cardiol, 2006, 112:1..
|
3. |
PARHAM C, CHIRICA M, TIMANS J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R[J]. J Immunol, 2002, 168(11):5699-5708..
|
4. |
OPPMANN B, LESLEY R, BLOM B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12[J]. Immunity,2000,13:715-725..
|
5. |
PARK H, LI ZX, YANG XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing Interleukin 17[J]. Nat lmmunol, 2005, 6(11):1133-1141..
|
6. |
LANGRISH CL, CHEN Y, BLUMENSCHEIN WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation[J].J Exp Med, 2005, 201: 233-240..
|
7. |
SONDEREGGER I, ROHN, TA, KURRER MO, et al.Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis[J]. Eur J Immunol, 2006, 36(11): 2849-2856..
|
8. |
RANGACHARI M,MAUERMANN N,MARTY RR,et al.T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17[J].J Exp Med, 2006, 203(8): 2009 -2019..
|